# ALK21-018: Effects of Medisorb® Naltrexone (VIVITROL®) on Alcohol Craving in Treatment-seeking, Alcohol-dependent Adults

> **NCT00511836** · PHASE4 · COMPLETED · sponsor: **Alkermes, Inc.** · enrollment: 31 (actual)

## Conditions studied

- Alcohol Dependence

## Interventions

- **DRUG:** VIVITROL 380 mg
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00511836
- **Lead sponsor:** Alkermes, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-07
- **Primary completion:** 2009-06
- **Final completion:** 2009-10
- **Target enrollment:** 31 (ACTUAL)
- **Last updated:** 2017-07-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00511836

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00511836, "ALK21-018: Effects of Medisorb® Naltrexone (VIVITROL®) on Alcohol Craving in Treatment-seeking, Alcohol-dependent Adults". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00511836. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*